Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

NCT00348998 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: bicalutamide
DRUG: goserelin acetate
RADIATION: radiation therapy

Sponsor

Virginia Mason Hospital/Medical Center